Identification of mycobacteria other than Mycobacterium tuberculosis requires considerable time and expertise. The development of rapid and simplified identification techniques has long been desired and is now possible through nucleic acid probe technology. A commercial kit (Gen-Probe Rapid Diagnostic System for Mycobacterium Avium Complex; Gen-Probe Corp., San Diego, Calif.) is available for culture confirmation and identification to species level of organisms belonging to the Mycobacterium avium complex. This test uses two separate 1251I-labeled cDNA probes, one homologous to rRNA derived from the type strain of M. avium and the other homologous to rRNA from Mycobacterium intracellulare. Hybridization is performed in solution with sonic extracts of mycobacterial suspensions, and the entire procedure can be completed in as little as 2 h.
M. avium complex organisms are of major clinical importance, causing tuberculosislike pulmonary disease, as well as local and disseminated infections in immunosuppressed patients (3, 6, 7) . The broadening acquired immune deficiency syndrome epidemic has significantly increased the frequency with which M. avium complex is isolated in the clinical laboratory. At 7 days. Colonies were removed from the agar surface, and the organisms were suspended in 2 ml of distilled water to obtain a turbidity equivalent to a no. 1 McFarland standard. A few glass beads were added to the suspension tubes to achieve homogeneity when M. tuberculosis isolates were tested. Suspensions not used immediately were stored at 4°C and tested within 24 h of preparation. Assay procedure. Reagents were provided by the manufacturer in kit form (Gen-Probe Rapid Diagnostic System for Mycobacterium Avium Complex). Each kit included the following: lysing reagent; two probe solutions, one each for M. avium and M. intracellulare, with 125I activities of 0.5 to 1.0 ,uCi/20-ml vial; hydroxyapatite separation suspension; and wash solution. Positive and negative control strains, prepared as described above for test organisms, were included in each run. The control strains used were M. avium ATCC 25291, M. intracellulare ATCC 13950, and M. tuberculosis ATCC 25177. For each isolate, two separate tubes containing lysing reagent were inoculated with 100 ,ul of bacterial suspension and then immersed in a sonicating water bath for 15 min at 60 to 70°C. Probe solution (1 ml) for either M. avium or M. intracellulare was added to each tube. All tubes were vortexed and then incubated in a 72°C water bath for 1 h. Separation suspension (4 ml) was added, and the tubes were vortexed and incubated for an additional 5 min. After removal of the tubes from the water bath, they were inverted 20 times before centrifugation (2,000 x g for 2 min; model TJ-6; Beckman Instruments, Inc., Fullerton, Calif.). The supernatant was decanted and discarded, and 4 ml of wash solution was added to the pellet. The pellets were resuspended by vortexing for 20 s and centrifuged as before. The supernatant was decanted and discarded, and the radioactivity of the adsorbent pellet was counted in a gamma counter (Picker Pace-1; Picker International, Inc., Norwalk, Calif. Biosafety guidelines for handling mycobacteria should be followed through sonication and incubation in the 720C water bath. Exposure to these conditions was sufficient to render organisms nonviable in the representative samples we examined. However, a conservative approach would be to treat the specimens as potentially infectious throughout the procedure and to decontaminate assay tubes and liquid before discarding them as radioactive waste. As with other molecular techniques for clinical laboratory use, the cost of reagents for the M. avium complex probe tests is considerably greater than that for the reagents used in conventional testing. Although it was beyond the scope of this study to perform accurate work time studies, the time savings realized through the use of the probe procedures would partially offset the difference in reagent costs. In addition, the availability to clinicians of a definitive organism identification days to weeks sooner than has been possible should reduce the overall cost of care and potential patient morbidity.
The successful application of nucleic acid probe technology for clinical microbiology diagnosis has been eagerly awaited. The probe test evaluated in this study was found to be a rapid and highly accurate procedure for identification of M. avium complex in culture and one which most laboratories should be capable of performing.
